Goldman Sachs Group »

Ambrx Biopharma shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Ambrx Biopharma shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Ambrx Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Ambrx Biopharma held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ambrx Biopharma by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.7M 400k 14.24

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Microsoft Corp CMN (MSFT)
Nvidia Corporation CMN (NVDA)
Apple CMN (AAPL)
Amazon CMN (AMZN)
Ishares Tr CMN (IWM)
Ishares Tr CMN (IVV)
Invesco Qqq Tr CMN (QQQ)
Meta Platforms CMN (META)
Alphabet CMN (GOOGL)
Vanguard Index Fds CMN (VOO)
Tesla CMN (TSLA)
Visa CMN (V)
Ishares Tr CMN (HYG)
Ishares Tr CMN (EFA)

View all positions for Goldman Sachs Group

Top funds holding Ambrx Biopharma

Federated Investors
Alliancebernstein
Altitude Crest Partners
Virtu Financial

View all funds holding Ambrx Biopharma